HCW Biologics (HCWB) Assets Average (2021 - 2025)
HCW Biologics' (HCWB) quarterly Assets Average came in at $25.0 million in Q4 2025, down 12.02% YoY from $28.4 million in Q4 2024, and down 8.08% on a QoQ basis from $27.2 million in Q3 2025.
HCW Biologics (HCWB) Assets Average (2021 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 5 years of Assets Average data on file, last reported at $25.0 million in Q4 2025.
- Quarterly Assets Average fell 12.02% year-over-year to $25.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25.0 million (down 12.02% YoY) and the FY2025 annual result came in at $27.4 million, down 6.8% from the prior year.
- Assets Average fell to $25.0 million in Q4 2025, from $27.2 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $55.0 million in Q4 2021 to a low of $25.0 million in Q4 2025.
- A 5-year average of $37.1 million and a median of $33.4 million in 2021 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average soared 42.23% — and 2024, when it slumped 34.76%.
- Tracing HCWB's Assets Average over 5 years: stood at $55.0 million in 2021, then dropped by 10.7% to $49.1 million in 2022, then plunged by 34.67% to $32.1 million in 2023, then slipped by 11.44% to $28.4 million in 2024, then fell by 12.02% to $25.0 million in 2025.
- The last three Assets Average figures came in at $25.0 million (Q4 2025), $27.2 million (Q3 2025), and $27.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | HCW Biologics | 2.93 Mn | 2.19 Mn | -93,887.00 | 25.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.98 Mn |
| Sep 30, 2025 | 27.18 Mn |
| Jun 30, 2025 | 27.60 Mn |
| Mar 31, 2025 | 28.26 Mn |
| Dec 31, 2024 | 28.40 Mn |
| Sep 30, 2024 | 26.69 Mn |
| Jun 30, 2024 | 28.62 Mn |
| Mar 31, 2024 | 29.47 Mn |
| Dec 31, 2023 | 32.07 Mn |
| Sep 30, 2023 | 37.55 Mn |
| Jun 30, 2023 | 41.51 Mn |
| Mar 31, 2023 | 45.17 Mn |
| Dec 31, 2022 | 49.08 Mn |
| Sep 30, 2022 | 49.38 Mn |
| Jun 30, 2022 | 49.18 Mn |
| Mar 31, 2022 | 52.24 Mn |
| Dec 31, 2021 | 54.96 Mn |
| Sep 30, 2021 | 34.72 Mn |